Compound ID | 52
Class: Antimicrobial peptide
| Spectrum of activity: | Gram-negative |
| Details of activity: | N. meningitidis |
| Institute where first reported: | Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden |
| Year first mentioned: | 2003 |
| Highest developmental phase: | Preclinical |
| Development status: | Experimental |
| External links: | |
| Citations: |
|